These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 29380693)
1. Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management. Khera L; Paul C; Kaul R Curr Drug Metab; 2018; 19(3):224-235. PubMed ID: 29380693 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1. Khera L; Paul C; Kaul R Virology; 2017 Jun; 506():110-120. PubMed ID: 28376369 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein interacts with cellular metastasis suppressor Nm23-H1 and promotes cell migration and invasion. Paul C; Khera L; Kaul R Arch Virol; 2019 May; 164(5):1271-1285. PubMed ID: 30859475 [TBL] [Abstract][Full Text] [Related]
4. Complex interactions between microRNAs and hepatitis B/C viruses. Fan HX; Tang H World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation. Ninio L; Nissani A; Meirson T; Domovitz T; Genna A; Twafra S; Srikanth KD; Dabour R; Avraham E; Davidovich A; Gil-Henn H; Gal-Tanamy M Cells; 2019 Nov; 8(11):. PubMed ID: 31694343 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-associated cancer. Lin MV; King LY; Chung RT Annu Rev Pathol; 2015; 10():345-70. PubMed ID: 25387053 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC. Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196 [TBL] [Abstract][Full Text] [Related]
8. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma]. Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066 [TBL] [Abstract][Full Text] [Related]
10. [Hepatitis C virus infection and hepatocarcinogenesis]. Szalay F Orv Hetil; 2010 Sep; 151(38):1524-9. PubMed ID: 20826376 [TBL] [Abstract][Full Text] [Related]
11. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53. Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals. Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276 [TBL] [Abstract][Full Text] [Related]
13. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related]
14. Role of Oxidative Stress in Hepatitis C Virus Induced Hepatocellular Carcinoma. Fu N; Yao H; Nan Y; Qiao L Curr Cancer Drug Targets; 2017; 17(6):498-504. PubMed ID: 27677955 [TBL] [Abstract][Full Text] [Related]
15. Role of antiviral therapy in the management of hepatocellular carcinoma. Guan YS; He Q Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161 [TBL] [Abstract][Full Text] [Related]
16. Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication. Motoyama H; Tamori A; Kubo S; Uchida-Kobayashi S; Takemura S; Tanaka S; Ohfuji S; Teranishi Y; Kozuka R; Kawamura E; Hagihara A; Morikawa H; Enomoto M; Murakami Y; Kawada N PLoS One; 2018; 13(3):e0194163. PubMed ID: 29534101 [TBL] [Abstract][Full Text] [Related]
17. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development. Ringelhan M; Heikenwalder M; Protzer U Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals. Hazari S; Hefler HJ; Chandra PK; Poat B; Gunduz F; Ooms T; Wu T; Balart LA; Dash S World J Gastroenterol; 2011 Jan; 17(3):300-12. PubMed ID: 21253388 [TBL] [Abstract][Full Text] [Related]
19. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882 [TBL] [Abstract][Full Text] [Related]
20. Angiogenic activity of hepatitis B and C viruses. Vrancken K; Paeshuyse J; Liekens S Antivir Chem Chemother; 2012 Jan; 22(4):159-70. PubMed ID: 22182803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]